Nature Reviews Clinical Oncology

From Wikipedia, the free encyclopedia
DisciplineOncology
LanguageEnglish
Edited byDiana Romero
Publication details
History2004–present
Publisher
Nature Publishing Group (United States)
FrequencyMonthly
66.675 (2020)
Standard abbreviations
ISO 4Nat. Rev. Clin. Oncol.
Indexing
ISSN1759-4774 (print)
1759-4782 (web)
Links

Nature Reviews Clinical Oncology is a peer-reviewed journal for oncologists. The journal was renamed from Nature Clinical Practice Oncology in April 2009.[1] Nature Reviews Clinical Oncology is one of eight Clinical Review journals published by the Nature Publishing Group. It covers research developments and clinical practice in oncology. The Chief Editor is Dr Diana Romero who works with an international Advisory Board of clinicians.

Coverage includes:[2]

  • Chemotherapy
  • Clinical pharmacology
  • Diagnosis
  • Epidemiology
  • Experimental therapies
  • Genetics
  • Health services, economics and outcomes research
  • Hematology
  • Hormonal therapies
  • Imaging
  • Immunotherapy
  • Medical oncology
  • Palliative care
  • Pathology
  • Pediatric oncology
  • Prevention
  • Radiotherapy
  • Screening
  • Signal transduction
  • Statistics
  • Surgical oncology
  • Targeted therapies

Indexed by ISI Nature Reviews Clinical Oncology received an impact factor of 53.276 as reported in the 2019 Journal Citation Reports.[3]

References[]

  1. ^ "Nature Reviews goes clinical" (Press release). "Nature Publishing Group. 28 January 2009. Retrieved 2010-06-09.
  2. ^ "Aims & Scope". Springer Nature. Retrieved 16 October 2020.
  3. ^ "Journals Ranked by Impact: Oncology". 2019 Journal Citation Reports. Web of Science (Sciences ed.). 2020.

External links[]


Retrieved from ""